Our Sponsors

  • Amicus Therapeutics - FOLD - Drug Fails

    Amicus will be a cheap buy Monday.

    How are you guys,

    After the market closed on friday, Amicus Therapeutics announced the failure of its Gaucher drug in its mid-stage. We are here to discuss a stock - FOLD - Amicus Therapeutics which is going to go much in red on monday. This is going to be a very shocking result and the stock will see a heavly sell off on Monday.


    Our strategy will be to get in as low as possible and wait for the best chance to get a huge profit. For day traders, it will be great to enter early during the first dip and tehn sell during the first peak. Don't wait till late day. If you want to hold for long, get in real low and hold for atleast a month. There is no chance of getting lower than what it will go lowest on monday.

    Amicus' Gaucher drug fails in mid-stage trial

    Amicus Therapeutics Inc FOLD said preliminary data from a mid-stage trial showed its experimental treatment for Gaucher disease did not meet endpoint.
    Full News here
    Amicus Therapeutics, Inc. Announces Preliminary Results of Phase 2 Study with Plicera for Gaucher Disease
    Once the data are final, the Company plans to further analyze and evaluate the results in collaboration with its partner, Shire Human Genetic Therapies, Inc. (Shire HGT), and, based on this work, will determine the appropriate next steps for the Plicera program. However, based on these preliminary results, the Company does not expect to advance Plicera into Phase 3 development at this time.  
     Whole News Here 
     We have to keep a keen eye on the stock to play it as a Day Trade. Keep your research active. Do look for news and tips for this stock.
    Keep visiting Hot Stocks Everyday. Do leave comments and  suggestions.
    We are here to make money and we will succeed. 
    God Bless,
    Be Rich.
     

0 comments:

Leave a Reply

Latest Posts